Michael Fürst has 20 years of experience in corporate responsibility, including business, social innovation, and integrity and compliance management, in business and academia. He is currently the head of social innovation and strategy at Novartis. His responsibilities span the development and implementation of the Novartis Corporate Responsibility and access to medicines strategy, inclusive business model innovation, innovative finance, ESG investor relations, measurement and evaluation, materiality analysis, global health policy, human rights, and more. Fürst is a key partner for the business to develop and run social business models such as Novartis Access or Novartis Healthy Family (Arogya Parivar). He was the Secretary of the Corporate Responsibility Board of Novartis and is an author and editor of articles and books.